The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan

OBJECTIVES/HYPOTHESIS: Dupilumab, which blocks the shared receptor component for interleukin‐4 and interleukin‐13, reduced polyp size, sinus opacification, and symptom severity, and was well tolerated in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in the SINUS‐52 study (NCT028984...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Laryngoscope
Autors principals: Fujieda, Shigeharu, Matsune, Shoji, Takeno, Sachio, Asako, Mikiya, Takeuchi, Makiko, Fujita, Hiroyuki, Takahashi, Yoshinori, Amin, Nikhil, Deniz, Yamo, Rowe, Paul, Mannent, Leda
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2020
Matèries:
Allergy, Rhinology, and Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8247406/
https://ncbi.nlm.nih.gov/pubmed/33226139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lary.29230
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars